The 3ml size offers a balanced option between minimal and extended use, making it ideal for moderate-length protocols and controlled peptide preparation
Ideal candidates include adults who have attempted medical weight loss through diet and exercise without achieving lasting results, those experiencing metabolic resistance related to age or hormonal changes, and individuals seeking to reduce cardiovascular risk factors alongside body weight
"Allowing compounding, while not the same as drug approval, is nonetheless a nod to regulatory recognition." This time, the FDA's advisors voted 7-5 in favor of putting MOTS-C on the compounding list
The authors hypothesize that this is due to the smaller macrocycle compared to iturin A
This combination may require additional estrogen management compared to TRT alone
Using them together covers both bases